Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I/II Clinical Trial to Evaluate the Safety and Immunogenicity of LC16m8, A Modified Vaccinia Vaccine, in Healthy Volunteers

NCT00103584 is registered in ClinicalTrials.gov with VaxGen as lead sponsor.

NCT NCT00103584
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00103584 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I/II Clinical Trial to Evaluate the Safety and Immunogenicity of LC16m8, A Modified Vaccinia Vaccine, in Healthy Volunteers
Lead sponsor
VaxGen
Phase
Phase 1/2
Overall status
Unknown status
Start date
October 31, 2004
Completion date
July 31, 2006
Enrollment
150
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

smallpox